LRRK2 G2019S Dopaminergic Neurons
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">LRRK2 G2019S Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
</table>
Overview
Lrrk2 G2019S Dopaminergic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<!-- taxonomy-enrichment --> [@cookson2015]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: dopaminergic neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
...LRRK2 G2019S Dopaminergic Neurons
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">LRRK2 G2019S Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
</table>
Overview
Lrrk2 G2019S Dopaminergic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<!-- taxonomy-enrichment --> [@cookson2015]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: dopaminergic neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
- [OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
- [PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
- [OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [PanglaoDB](https://panglaodb.se/)
Introduction
Lrrk2 G2019S Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LRRK2 G2019S Dopaminergic Neurons are neurons carrying the G2019S mutation in the LRRK2 gene, the most common genetic cause of familial Parkinson's disease (PD). These neurons model the molecular mechanisms underlying LRRK2-associated neurodegeneration.
Genetic Background
The LRRK2 (Leucine-Rich Repeat Kinase 2) gene encodes a large multi-domain protein with GTPase and kinase activity. The G2019S mutation, located in the kinase domain, increases kinase activity by approximately 2-3 fold ([West et al., 2005](https://pubmed.ncbi.nlm.nih.gov/15702230/)). This mutation accounts for 5-10% of familial PD cases and 1-3% of sporadic PD cases worldwide.
Cellular Characteristics
Kinase Hyperactivity
The G2019S mutation results in:
- Increased autophosphorylation of LRRK2
- Enhanced phosphorylation of downstream substrates including Rab proteins
- Altered cellular trafficking pathways
Mitochondrial Dysfunction
LRRK2 G2019S neurons exhibit:
- Reduced mitochondrial complex I activity
- Increased mitochondrial DNA damage
- Impaired mitophagy clearance
- Elevated reactive oxygen species (ROS) production
Synaptic Dysfunction
These neurons show:
- Reduced dopamine release capacity
- Impaired synaptic vesicle recycling
- Altered axonal transport of synaptic proteins
- Degeneration of synaptic terminals prior to cell body loss
Protein Aggregation Susceptibility
LRRK2 hyperactivity promotes:
- Enhanced alpha-synuclein phosphorylation at Ser129
- Increased aggregation propensity
- Impaired autophagy-lysosomal pathway function
Pathophysiological Mechanisms
Neuroinflammation
LRRK2 is highly expressed in microglia, and the G2019S mutation drives:
- Chronic microglial activation
- Increased TNF-α and IL-1β release
- Neurotoxic microglial phenotype
Axonal Degeneration
The G2019S mutation specifically affects:
- microtubule-based axonal transport
- Mitochondrial distribution along axons
- Synaptic protein trafficking
Therapeutic Implications
LRRK2 Kinase Inhibitors
Several LRRK2 inhibitors are in clinical development:
- DNL151 (Denali Therapeutics)
- BIIB122 (Biogen/Denali)
- These aim to reduce kinase activity to normal levels
Gene Therapy Approaches
- RNA interference to reduce mutant LRRK2 expression
- CRISPR-based allele-specific editing
- Viral vector delivery of protective variants
Overview
Lrrk2 G2019S Dopaminergic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Lrrk2 G2019S Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Cross-References
- LRRK2 Gene
- LRRK2 Protein
- [Parkinson's Disease](/diseases/parkinsons-disease)
- Dopaminergic Neurons
- [Alpha-Synuclein](/proteins/alpha-synuclein) Mitochondrial Dysfunction
See Also
- [Proteins Index](/proteins)
- [Genes Index](/genes)
- [Diseases Index
](/diseases/diseases-index)